Scaffold distributions in bioactive molecules, clinical trials compounds, and drugs

ChemMedChem

Volumn 5, Issue 2, 2010, Pages 187-190

  Hu, Ye ^a   Bajorath, Jürgen ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Bioactive molecules; Clinical trials compounds; Drugs; Molecular scaffolds; Scaffold distributions; Statistical analysis

Indexed keywords

MOLECULAR SCAFFOLD;

ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL BINDING; CHEMICAL BOND; CONTROLLED STUDY; DATA BASE; PRIORITY JOURNAL;

CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; DRUG DISCOVERY; DRUG EVALUATION; MODELS, CHEMICAL; MODELS, MOLECULAR; PHARMACEUTICAL PREPARATIONS;

EID: 75749154412     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200900419     Document Type: Article

References (28)

1. G. W. Bemis, M. A. Murcko, J. Med. Chem. 1996, 39, 2887-2893.
2. A. Schuffenhauer, P. Ertl, S. Roggo, S. Wetzel, M. A. Koch, H. Waldmann, J. Chem. Inf. Model. 2007, 47, 47-58.
3. A. M. Clark, P. Labute, J. Med. Chem. 2009, 52, 469-483.
4. S. Renner, W. A. L. Van Otterlo, M. D. Seoane, S. Möcklinghoff, B. Hoffmann, S. Wetzel, A. Schuffenhauer, P. Ertl, T. I. Oprea, D. Steinhilber, L. Brunsveld, D. Rauh, H. Waldmann, Nat. Chem. Biol. 2009, 5, 585-592.
5. R. P. Sheridan, J. Chem. Inf. Comput. Sci. 2003, 43, 1037-1050.
6. J. Batista, J. Bajorath, J. Chem. Inf. Model. 2007, 47, 1405-1413.
7. J. J. Sutherland, R. E. Higgs, I. Watson, M. Vieth, J. Med. Chem. 2008, 51, 2689-2700.
8. E. Lounkine, J. Auer, J. Bajorath, J. Med. Chem. 2008, 51, 5342-5348.
9. G. Müller, Drug Discovery Today 2003, 8, 681-691.
10. D. M. Schnur, M. A. Hermsmeier, A. J. Tebben, J. Med. Chem. 2006, 49, 2000-2009.
11. A. M. Aronov, B. McClain, C. S. Moody, M. A. Murcko, J. Med. Chem. 2008, 51, 1214-1222.
12. D. A. Erlanson, R. S. McDowell, T. O'Brien, J. Med. Chem. 2004, 47, 3463-3482.
13. P. J. Hajduk, J. Greer, Nat. Rev. Drug Discovery 2007, 6, 211-219.
14. M. G. Siegel, M. Vieth, Drug Discovery Today 2007, 12, 71-79.
15. M. Fischer, R. E. Hubbard, Mol. Interventions 2009, 9, 22-30.
16. T. I. Oprea, J. Comput. Aided Mol. Des. 2000, 14, 251-264.
17. I. Muegge, Med. Res. Rev. 2003, 23, 302-321.
18. C. A. Lipinski, Drug Discovery Today Technol. 2004, 1, 337-341.
19. T. I. Oprea, T. K. Allu, D. C. Fara, R. F. Rad, L. Ostopovici, C. G. Bologa, J. Comput. Aided Mol. Des. 2007, 21, 113-119.
20. I. Kola, J. Landis, Nat. Rev. Drug Discovery 2004, 3, 711-716.
21. P. D. Leeson, B. Springthorpe, Nat. Rev. Drug Discovery 2007, 6, 881-890.
22. T. Liu, Y. Lin, X. Wen, R. N. Jorissen, M. K. Gilson, Nucleic Acids Res. 2007, 35, D198- D201.
23. MDL Drug Data Report (MDDR), Symyx Software: San Ramon, CA (USA) 2007, http://www.symyx.com (accessed December 3, 2009).
24. D. S. Wishart, C. Knox, A. C. Guo, D. Chen, S. Shrivastava, D. Tzur, B. Gautam, M. Hassanali, Nucleic Acids Res. 2008, 36, D901-D906.
25. Scitegic Pipeline Pilot, Accelrys, Inc.: San Diego, CA (USA) 2009, http:// accelrys.com/products/scitegic (accessed December 3, 2009).
26. P. Shannon, A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, D. Ramage, N. Amin, B. Schwikowski, T. Ideker, Genome Res. 2003, 13, 2498-2504.
27. P. Willett, J. M. Barnard, G. M. Downs, J. Chem. Inf. Comput. Sci. 1998, 38, 983-996.
28. MACCS structural keys, Symyx Software: San Ramon, CA (USA) 2008, http://www.symyx.com (accessed December 3, 2009).